SK Capital to Divest Noramco API Assets to Siegfried as Halo Pharma Emerges as Stand-Alone Drug Product CDMO

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) The...

January 29, 2026 | Thursday | News
Gannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation Capabilities

Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capit...

January 28, 2026 | Wednesday | News
HanchorBio and WuXi Biologics Enter Strategic Collaboration to Advance Next-Generation Fusion Proteins

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseas...

January 27, 2026 | Tuesday | News
Charles River Laboratories International And Gazi University Faculty of Medicine Advance Rare Disease Gene Therapy Through Strategic CDMO Collaboration

Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, announced a gene therapy contract developme...

January 22, 2026 | Thursday | News
Rakuten Medical Partners With LOTTE Biologics to Expand Manufacturing for Alluminox® Photoimmunotherapy

  Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P....

January 15, 2026 | Thursday | News
Jubilant Biosys Opens Integrated Discovery and Scale-Up Facility to Meet Rising Global Biopharma Demand

 Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India ...

January 14, 2026 | Wednesday | News
Charles River Laboratories Charts A Deliberate Leadership Transition To Power Its Next Phase Of Growth

Charles River Laboratories’ announcement of a planned leadership transition marks one of the most consequential succession moments in the global pr...

January 09, 2026 | Friday | News
Transcenta Therapeutics Enters Strategic Bioprocessing Collaboration With EirGenix

  Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-inte...

December 31, 2025 | Wednesday | News
Hope Biosciences Reports Phase II Breakthrough Showing Significant Motor Improvement in Parkinson’s Disease

Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF)  shares positive top-line results of a Phase II clinical tri...

December 24, 2025 | Wednesday | News
Samsung Biologics Enters U.S. Manufacturing with $280M Rockville Site Acquisition from GSK

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional inv...

December 23, 2025 | Tuesday | News
Symeres Secures SBTi Approval for Science-Based Emissions Reduction Targets

Symeres, a leading contract research, development, and manufacturing organisation (CRDMO), has received its first approval from the Science Based Targets i...

December 19, 2025 | Friday | News
Thermo Fisher Launches Next-Gen Chemically Defined Media to Accelerate Scalable Plasmid DNA Production

  New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scien...

December 16, 2025 | Tuesday | News
Tjoapack Announces Major U.S. Expansion with New 170,000-sq-ft Pharmaceutical Packaging Facility

Tjoapack, a leading global contract packaging organization, has announced a significant strategic investment to expand its operational footprint in the U.S...

December 10, 2025 | Wednesday | News
Akadeum Launches CDMO Alliance With ElevateBio and Charles River as Inaugural Members

Cell therapy manufacturers Charles River and ElevateBio are named as inaugural members Akadeum Life Sciences, the leader in buoyant cell separation, ann...

December 10, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close